Adage Capital Partners Gp, L.L.C. Gh Research PLC Transaction History

Adage Capital Partners Gp, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$8.99 - $19.87 $1.35 Million - $2.98 Million	-150,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$14.1 - $27.9 $3.53 Million - $6.98 Million	-250,000 Reduced 62.5%	150,000 $3.5 Million
Q3 2021 Nov 15, 2021	SELL	$16.51 - $23.68 $1.07 Million - $1.54 Million	-65,000 Reduced 13.98%	400,000 $8.82 Million
Q2 2021 Aug 16, 2021	BUY	$19.25 - $21.73 $8.95 Million - $10.1 Million	465,000 New	465,000 $10.1 Million

27.8M

2.8K

3.8K

Ticker GHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,020,800
Market Cap $427M
Description
GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.